Product Specification
| Formula: | C203H311N55O60S |
| |
| MW: | 4514.1 |
| |
| Quantity: | *Sold as net peptide weight. |
| |
| Purity: | ≥97% (HPLC) |
| |
| Appearance: | White to off-white lyophilized powder. |
| |
| Sequence: | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH |
| |
| Solubility: | Soluble in 5% acetic acid. |
| |
| Shipping: | AMBIENT |
| |
| Long Term Storage: | -20°C |
| |
Product Literature References
Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease: D. Goldgaber, et al.; Science
235, 877 (1987),
Abstract;
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor: J. Kang, et al.; Nature
325, 733 (1987),
Abstract;
A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease: J. Murrell, et al.; Science
254, 97 (1991),
Abstract;
Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition: C.J. Barrow & M.G. Zagorski; Science
253, 179 (1991),
Abstract;